Gryphon Analytics Copyright 2012-2017

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Google+ Icon

Patent cliff causes negative outlook for global pharma | Healthcare Finance News

November 1, 2012

The outlook for the global pharmaceutical industry remains negative as any potential revenue over the next 12-18 months is likely to be offset by losses from the upcoming expirations of major patents -  known as the patent cliff -  according to a new industry report by Moody’s Investors Service.

Share on Facebook
Share on Twitter
Please reload

Featured Review

U.S. Healthcare Outlook

October 24, 2014

Please reload

Tag Cloud
Please reload